The evolving use of arsenic in pharmacotherapy of malignant disease.
about
Lung tumors in mice induced by "whole-life" inorganic arsenic exposure at human-relevant dosesApoptotic efficacy of etomoxir in human acute myeloid leukemia cells. Cooperation with arsenic trioxide and glycolytic inhibitors, and regulation by oxidative stress and protein kinase activitiesThe clinical activity of arsenic trioxide, ascorbic acid, ifosfamide and prednisone combination therapy in patients with relapsed and refractory multiple myelomaGlobal Fitness Profiling Identifies Arsenic and Cadmium Tolerance Mechanisms in Fission YeastNucleoli and stress granules: connecting distant relatives.Update on emerging treatments for chronic myeloid leukemia.Uptake, Metabolic Effects and Toxicity of Arsenate and Arsenite in Astrocytes.Arsenic Triglutathione [As(GS)3] Transport by Multidrug Resistance Protein 1 (MRP1/ABCC1) Is Selectively Modified by Phosphorylation of Tyr920/Ser921 and Glycosylation of Asn19/Asn23.Grape seed and skin extract protects against arsenic trioxide induced oxidative stress in rat heart.Arsenate stimulates glutathione export from viable cultured rat cerebellar granule neurons.
P2860
Q24707867-7F87EBF7-6FD2-401B-9D5F-ABA7642D89C6Q28542724-B8E7C786-CDE9-4737-A3BD-C30D6A3A9010Q33422349-C3C2F596-DC4A-4892-B7A0-457A988C9A2FQ34538421-983E5442-823B-43BF-8FA8-F68B7AF1C4C9Q38225814-78F4FAE9-14FA-4FE1-9F14-9A4F2144E459Q38397515-99B139AE-6CB9-4E62-8FE7-DCB30C3202B9Q38415412-08F73AAA-D356-42E1-A404-6E7353BE8BE8Q38764633-B010AFEA-57BA-4A33-B35C-3D9B93CC453FQ40330350-3DA0FD00-8D28-4883-A6BB-662EC7A6FD8FQ48413648-BA0D0BC5-1450-4169-A4C5-3C7FAA706308
P2860
The evolving use of arsenic in pharmacotherapy of malignant disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The evolving use of arsenic in pharmacotherapy of malignant disease.
@en
type
label
The evolving use of arsenic in pharmacotherapy of malignant disease.
@en
prefLabel
The evolving use of arsenic in pharmacotherapy of malignant disease.
@en
P2093
P2860
P1433
P1476
The evolving use of arsenic in pharmacotherapy of malignant disease.
@en
P2093
Athena Kritharis
Daniel R Budman
Thomas P Bradley
P2860
P304
P356
10.1007/S00277-013-1707-3
P577
2013-03-15T00:00:00Z